Pacritinib in CMML
Condition(s):Chronic Myelomonocytic LeukemiaLast Updated:December 6, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Chronic Myelomonocytic LeukemiaLast Updated:December 6, 2023Not yet recruiting
Condition(s):Acute Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic SyndromeLast Updated:April 22, 2015Terminated
Condition(s):Myelodysplastic Syndromes (MDS); Chronic Myelomonocytic Leukemia (CMML); Acute Myelogenous Leukemia (AML)Last Updated:November 8, 2019Completed
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid LeukemiaLast Updated:October 31, 2022Withdrawn
Condition(s):Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesLast Updated:February 13, 2024Active, not recruiting
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid LeukemiaLast Updated:August 4, 2020Completed
Condition(s):Myelodysplastic Syndromes (MDS); Chronic Myelomonocytic Leukemia (CMML); Acute Myeloid Leukemia (AML)Last Updated:December 19, 2020Completed
Condition(s):Myelodysplastic Syndromes; Juvenile Myelomonocytic LeukemiaLast Updated:May 24, 2023Active, not recruiting
Condition(s):Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myeloproliferative NeoplasmLast Updated:March 20, 2024Recruiting
Condition(s):Myelofibrosis; Myeloid Metaplasia; Agnogenic Myeloid Metaplasia; Chronic Myelomonocytic LeukemiaLast Updated:December 23, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.